Embecta
Embecta designs and manufactures insulin-delivery devices—primarily pen needles and syringes—for people living with diabetes, distributing through pharmacies, hospitals, and healthcare channels in over 100 countries. Formed in 2022 as a spin-off from Becton, Dickinson and Company (BD), the public company is headquartered in Parsippany, New Jersey. It builds on a century of diabetes care heritage, with tens of millions of patients using its products worldwide.
Open Positions at Embecta
1 open position
Kolkāta, India +3 moreSenior
Sr Data Architect responsible for building and operating scalable cloud data pipelines and lakehouse solutions across Azure, Databricks, and SAP. The role supports enterprise BI, AI/ML, data governance, and reliable data products while mentoring data engineers.